Abstract 3338. Concurrent treatment with Pim kinase inhibitor enhances the efficacy of FLT3 inhibitors in AML with FLT3-ITD through GSK-3βactivation and GSK-3β-mediated enhanced proteasomal degradation of c-Myc and Mcl-1.
What are your long-term goals?
Cancer research, drug development, cancer disparity research, and outreach
Please share information about how the pandemic has impacted your research over the last two years.
The pandemic has made it very difficult for me to complete my research. I missed five months in the lab due to the shutdown. I also had to alter my work schedule to make sure that my daughter was able to attend virtual schooling.